Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asthma therapy: theophylline

N C Thomson1

  • 1University of Glasgow, Glasgow, United Kingdom. n.c.thomson@clinmed.gla.ac.uk

Canadian Respiratory Journal
|September 30, 1998
PubMed
Summary
This summary is machine-generated.

Theophylline offers bronchodilator benefits for asthma but its anti-inflammatory role needs more research. It serves as an add-on therapy for difficult-to-control asthma, but inhaled options are preferred first.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Findings from a pilot Randomised trial of an Asthma Internet Self-management Intervention (RAISIN).

BMJ open·2016
Same author

Decreased FEV1 % in asthmatic adults in Scottish homes with high Environmental Relative Moldiness Index values.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Same author

Novel therapies targeting eosinophilic inflammation in asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

Arachidonic acid metabolites and enzyme transcripts in asthma are altered by cigarette smoking.

Allergy·2014
Same author

Effects of a FLAP inhibitor, GSK2190915, in asthmatics with high sputum neutrophils.

Pulmonary pharmacology & therapeutics·2013
Same author

Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2012
Same journal

The Prognostic Significance of Advanced Lung Cancer Inflammation Index in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Using Noninvasive Ventilatory Support.

Canadian respiratory journal·2026
Same journal

Effectiveness of Individualized Nursing in Perioperative Management of Patients With Obstructive Sleep Apnea: A Retrospective Cohort Study.

Canadian respiratory journal·2026
Same journal

Preliminary Study on the Effect of Bronchial Epithelial Cell-Released Autophagosome (BA)-Induced Neutrophils on Bronchial Epithelial Cells.

Canadian respiratory journal·2026
Same journal

Integrated Mindfulness and Cardiopulmonary Rehabilitation Improves Cardiopulmonary Performance and Psychological Stress in Pulmonary Arterial Hypertension.

Canadian respiratory journal·2026
Same journal

Postpartum Venous Thromboembolism: Altitudinal Gradients, Decadal Trends, and PE-Specific Risk Profiling in Highland Populations.

Canadian respiratory journal·2026
Same journal

Cortex Mori Radicis Mitigates Inflammation and Fibrosis in Pulmonary Fibrosis Through PI3K/AKT Pathway Suppression.

Canadian respiratory journal·2026
See all related articles

Area of Science:

  • Pharmacology
  • Respiratory Medicine
  • Clinical Therapeutics

Background:

  • Theophylline is a bronchodilator with established bronchoprotective effects in asthma management.
  • The precise contribution of its anti-inflammatory properties to overall clinical efficacy is not fully understood.
  • Current guidelines suggest theophylline as a potential add-on therapy for patients with inadequately controlled asthma.

Purpose of the Study:

  • To evaluate the role and optimal positioning of theophylline in asthma management.
  • To compare theophylline with other add-on therapies for asthma control.
  • To clarify the significance of theophylline's anti-inflammatory actions in clinical practice.

Main Methods:

  • Review of existing literature on theophylline's pharmacology and clinical use in asthma.

Related Experiment Videos

  • Analysis of treatment guidelines and comparative studies.
  • Assessment of theophylline's efficacy and safety profile in relation to other asthma medications.

    • Main Results:

    • Theophylline is indicated as an additional long-term control medication for asthma not managed by short-acting beta-agonists and inhaled steroids.
    • Inhaled long-acting beta-agonists are generally recommended over oral theophylline for most patients.
    • Comparative data on the efficacy and side effects of oral theophylline versus oral leukotriene modulators as add-on therapy are lacking.

    Conclusions:

    • Theophylline remains a viable option for specific asthma patient groups requiring additional long-term control.
    • Further research is needed to establish theophylline's place relative to leukotriene modulators in add-on asthma therapy.
    • The anti-inflammatory effects of theophylline require further investigation to fully understand its clinical impact.